Sufentanil combined with parecoxib sodium inhibits proliferation and metastasis of HER2-positive breast cancer cells and regulates epithelial-mesenchymal transition.

Xu, Sunmian; Li, Xiaohui; Li, Wenbin; Ma, Nina; Ma, Hongjun; Cui, Jian; You, Xiaogang; Chen, Xuexin

Xu, Sunmian; Li, Xiaohui; Li, Wenbin; Ma, Nina; Ma, Hongjun; Cui, Jian; You, Xiaogang; Chen, Xuexin.

Afiliación

Xu S; School of Clinical Medicine, Ningxia Medical University, 750004, Yinchuan, China.
Li X; Huashan Hospital, Fudan University, 200040, Shanghai, China.
Li W; General Hospital of Ningxia Medical University, 750004, Yinchuan, China.
Ma N; General Hospital of Ningxia Medical University, 750004, Yinchuan, China.
Ma H; General Hospital of Ningxia Medical University, 750004, Yinchuan, China.
Cui J; General Hospital of Ningxia Medical University, 750004, Yinchuan, China.
You X; General Hospital of Ningxia Medical University, 750004, Yinchuan, China.
Chen X; General Hospital of Ningxia Medical University, 750004, Yinchuan, China.

Clin Exp Metastasis ; 40(2): 149-160, 2023 04.

Article en En | MEDLINE | ID: mdl-36807216

Asunto(s)

Neoplasias de la Mama; Animales; Femenino; Humanos; Ratones; Neoplasias de la Mama/patología; Línea Celular Tumoral; Movimiento Celular; Proliferación Celular; Transición Epitelial-Mesenquimal; Sufentanilo/farmacología; Factor A de Crecimiento Endotelial Vascular

Palabras clave

Epithelial-mesenchymal transition; HER2-positive breast cancer; Metastasis; Parecoxib sodium; Proliferation; Sufentanil

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Clin Exp Metastasis Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google